Availability: BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells

BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy

Saved in:

Bibliographic Details
Main Authors:	Dörrie, Jan (Author), Babalija, Lek (Author), Hoyer, Stefanie (Author), Gerer, Kerstin F. (Author), Schuler, Gerold (Author), Heinzerling, Lucie (Author), Schaft, Niels (Author)
Format:	Electronic eBook
Language:	English
Published:	Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg 2018
Subjects:	BRAF inhibitor MEK inhibitor kinase inhibitor CAR-T cell dabrafenib trametinib vemurafenib cobimetinib melanoma immunotherapy
Links:	https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-108494 http://d-nb.info/1186378492/34 https://open.fau.de/handle/openfau/10849
Physical Description:	1 Online-Ressource

Staff View

MARC


LEADER	00000nam a2200000zc 4500
001	BV045911623
003	DE-604
005	20190730
007	cr\|uuu---uuuuu
008	190605s2018 gw o\|\|\|\| 00\|\|\| eng d
015			\|a 19,O06 \|2 dnb
016	7		\|a 1186378492 \|2 DE-101
024	7		\|a urn:nbn:de:bvb:29-opus4-108494 \|2 urn
035			\|a (OCoLC)1111874471
035			\|a (DE-599)DNB1186378492
040			\|a DE-604 \|b ger \|e rda
041	0		\|a eng
044			\|a gw \|c XA-DE-BY
049			\|a DE-29
084			\|a 610 \|2 sdnb
100	1		\|a Dörrie, Jan \|e Verfasser \|4 aut
245	1	0	\|a BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells \|b Consequences for Adoptive T-Cell Therapy \|c Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F. Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft
264		1	\|a Erlangen \|b Friedrich-Alexander-Universität Erlangen-Nürnberg \|c 2018
300			\|a 1 Online-Ressource
336			\|b txt \|2 rdacontent
337			\|b c \|2 rdamedia
338			\|b cr \|2 rdacarrier
583	1		\|a Archivierung/Langzeitarchivierung gewährleistet \|5 DE-101 \|2 pdager
653			\|a BRAF inhibitor
653			\|a MEK inhibitor
653			\|a kinase inhibitor
653			\|a CAR-T cell
653			\|a dabrafenib
653			\|a trametinib
653			\|a vemurafenib
653			\|a cobimetinib
653			\|a melanoma
653			\|a immunotherapy
700	1		\|a Babalija, Lek \|e Verfasser \|4 aut
700	1		\|a Hoyer, Stefanie \|e Verfasser \|4 aut
700	1		\|a Gerer, Kerstin F. \|e Verfasser \|4 aut
700	1		\|a Schuler, Gerold \|e Verfasser \|4 aut
700	1		\|a Heinzerling, Lucie \|e Verfasser \|4 aut
700	1		\|a Schaft, Niels \|e Verfasser \|4 aut
787	0	8	\|i Sonderdruck aus \|t International Journal of Molecular Sciences \|g Vol. 19 (2018) \|o 10.3390/ijms19010289
856	4	0	\|u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-108494 \|x Resolving-System \|z kostenfrei \|3 Volltext
856	4	0	\|u http://d-nb.info/1186378492/34 \|x Langzeitarchivierung Nationalbibliothek \|z kostenfrei \|3 Volltext
856	4	0	\|u https://open.fau.de/handle/openfau/10849 \|x Verlag \|z kostenfrei \|3 Volltext
912			\|a ebook
943	1		\|a oai:aleph.bib-bvb.de:BVB01-031294188

Record in the Search Index

_version_	1818985650808946688
any_adam_object
author	Dörrie, Jan Babalija, Lek Hoyer, Stefanie Gerer, Kerstin F. Schuler, Gerold Heinzerling, Lucie Schaft, Niels
author_facet	Dörrie, Jan Babalija, Lek Hoyer, Stefanie Gerer, Kerstin F. Schuler, Gerold Heinzerling, Lucie Schaft, Niels
author_role	aut aut aut aut aut aut aut
author_sort	Dörrie, Jan
author_variant	j d jd l b lb s h sh k f g kf kfg g s gs l h lh n s ns
building	Verbundindex
bvnumber	BV045911623
collection	ebook
ctrlnum	(OCoLC)1111874471 (DE-599)DNB1186378492
discipline	Medizin
format	Electronic eBook
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02145nam a2200565zc 4500</leader><controlfield tag="001">BV045911623</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190730 </controlfield><controlfield tag="007">cr\|uuu---uuuuu</controlfield><controlfield tag="008">190605s2018 gw o\|\|\|\| 00\|\|\| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">19,O06</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1186378492</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-108494</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1111874471</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1186378492</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Dörrie, Jan</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells</subfield><subfield code="b">Consequences for Adoptive T-Cell Therapy</subfield><subfield code="c">Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F. Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BRAF inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MEK inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">kinase inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CAR-T cell</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dabrafenib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">trametinib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vemurafenib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cobimetinib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">melanoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Babalija, Lek</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hoyer, Stefanie</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gerer, Kerstin F.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schuler, Gerold</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Heinzerling, Lucie</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schaft, Niels</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">International Journal of Molecular Sciences</subfield><subfield code="g">Vol. 19 (2018)</subfield><subfield code="o">10.3390/ijms19010289</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-108494</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://d-nb.info/1186378492/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/10849</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031294188</subfield></datafield></record></collection>
id	DE-604.BV045911623
illustrated	Not Illustrated
indexdate	2024-12-20T18:38:17Z
institution	BVB
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-031294188
oclc_num	1111874471
open_access_boolean	1
owner	DE-29
owner_facet	DE-29
physical	1 Online-Ressource
psigel	ebook
publishDate	2018
publishDateSearch	2018
publishDateSort	2018
publisher	Friedrich-Alexander-Universität Erlangen-Nürnberg
record_format	marc
spelling	Dörrie, Jan Verfasser aut BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F. Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg 2018 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager BRAF inhibitor MEK inhibitor kinase inhibitor CAR-T cell dabrafenib trametinib vemurafenib cobimetinib melanoma immunotherapy Babalija, Lek Verfasser aut Hoyer, Stefanie Verfasser aut Gerer, Kerstin F. Verfasser aut Schuler, Gerold Verfasser aut Heinzerling, Lucie Verfasser aut Schaft, Niels Verfasser aut Sonderdruck aus International Journal of Molecular Sciences Vol. 19 (2018) 10.3390/ijms19010289 https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-108494 Resolving-System kostenfrei Volltext http://d-nb.info/1186378492/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext https://open.fau.de/handle/openfau/10849 Verlag kostenfrei Volltext
spellingShingle	Dörrie, Jan Babalija, Lek Hoyer, Stefanie Gerer, Kerstin F. Schuler, Gerold Heinzerling, Lucie Schaft, Niels BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy
title	BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy
title_auth	BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy
title_exact_search	BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy
title_full	BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F. Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft
title_fullStr	BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F. Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft
title_full_unstemmed	BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F. Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft
title_short	BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells
title_sort	braf and mek inhibitors influence the function of reprogrammed t cells consequences for adoptive t cell therapy
title_sub	Consequences for Adoptive T-Cell Therapy
url	https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-108494 http://d-nb.info/1186378492/34 https://open.fau.de/handle/openfau/10849
work_keys_str_mv	AT dorriejan brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy AT babalijalek brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy AT hoyerstefanie brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy AT gererkerstinf brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy AT schulergerold brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy AT heinzerlinglucie brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy AT schaftniels brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy

Availability

‌

Order via interlibrary loan Read online (freely available)